There was a time when the media openly covered vaccine injuries, safety failures, and mandates. Did the evidence change… or something else?
In 1982, an NBC affiliate station in Washington, D.C., produced a documentary called “DPT: Vaccine Roulette.”
It got such a huge reaction, the station re-aired it twice. The big NBC promoted it. It even won an Emmy.
All because it asked one vital question: Is the DPT vaccine more dangerous than the disease itself?
44 years later, a film like this would never win an Emmy, never be funded by mainstream television, nor receive positive media coverage. You can’t even watch the film on YouTube anymore.
The question we have to ask is: why?
Did the evidence change… or something else?
“Thou shalt not bow down thyself to them, nor serve them: for I the LORD thy God am a jealous God, visiting the iniquity of the fathers upon the children unto the third and fourth generation of them that hate me; - Exodus 20:5
In memory of those who “died suddenly” in the United States and worldwide, May 4-11, 2026
Actors Jonathan Tiersten (Sleepaway Camp), Angelina Armani (38, Fear Clinic); composer Mark Smythe; LDS missionary leader W. Mark Bassett; hoopster José “Piculín” Ortiz; sports journo Pat Caputo;
A survey of the likely global toll of COVID “vaccination,” based on the reports collected by our worldwide team of researchers this past week.
“Thou shalt not bow down thyself to them, nor serve them: for I the LORD thy God am a jealous God, visiting the iniquity of the fathers upon the children unto the third and fourth generation of them that hate me; - Exodus 20:5
Hantavirus Patents: Who Owns Them? And When Does a "Vaccine" Become the Pathogen?
Hantavirus and a key USA WHO collaborating Centre are connected, raising many questions...
Question: Would you want a modified hemorrhagic fever “virus”, capable of entering human cells but allegedly engineered not to fully spread, injected into you? This is what a hantavirus “vaccine” may be.
Question: Would you be surprised to hear that hantavirus lung infection is listed among Pfizer’s COVID-19 vaccine list of severe adverse drug reactions?
At what point does an engineered vaccine platform begin to resemble the “virus” it was designed to prevent?
For most people, the word “vaccine” still evokes something simple: a weakened virus, a harmless protein, or a shot that teaches the immune system to fight disease. But the COVID-19 scam has shown that what are called vaccines can no longer be considered harmless.
Today’s “vaccine” science increasingly involves genetically engineered viruses “viral systems”, synthetic biology, programmable RNA platforms, and modified viruses. Thus, the question At what point does an engineered vaccine platform begin to resemble the “virus” it was designed to prevent? sits quietly beneath a growing heap of patents connected to emerging viruses such as hantaviruses, Nipah virus, and Crimean-Congo hemorrhagic fever virus (CCHF).
“Thou shalt not bow down thyself to them, nor serve them: for I the LORD thy God am a jealous God, visiting the iniquity of the fathers upon the children unto the third and fourth generation of them that hate me; - Exodus 20:5
20-YEAR CIA VETERAN CONFIRMS ANTHONY FAUCI AND THE CIA INTENTIONALLY COVERED UP COVID’S LAB ORIGIN
The CIA knew SARS-CoV-2 came from a lab in 2020, buried it, and Anthony Fauci helped make it happen.
My Testimony to the EU Parliament
"The WHO's decision to send Peter Daszak to Wuhan to investigate the origin of SARS-CoV-2 is like the LAPD sending Charles Manson to investigate the Sharon Tate murder."
“Thou shalt not bow down thyself to them, nor serve them: for I the LORD thy God am a jealous God, visiting the iniquity of the fathers upon the children unto the third and fourth generation of them that hate me; - Exodus 20:5
Louisiana to Vote on First-in-the-Nation Resolution Backing Fenbendazole for Cancer Treatment
HR 174 encourages state health officials to examine fenbendazole’s cancer-fighting potential as studies and patient reports fuel growing demand for expanded access.
The Louisiana House of Representatives is scheduled to vote Monday on a first-in-the-nation resolution urging the state surgeon general and Louisiana Department of Health to formally assess fenbendazole as a potential treatment for cancer in humans and develop recommendations for engaging federal regulators on expedited review pathways.
House Resolution 174 (HR 174), sponsored by State Representative Charles Owen (R-30), passed the House Committee on Health and Welfare unanimously in a 10-0 vote and is now scheduled for floor debate on May 18, 2026.
The measure represents a major health freedom milestone, signaling growing willingness among lawmakers to challenge traditional gatekeeping around experimental and repurposed therapies—especially for patients facing life-threatening illnesses with limited treatment options.
If adopted, the HR 174 would formally request that Louisiana’s top public health officials evaluate whether fenbendazole could potentially be advanced toward human authorization for cancer treatment or other conditions and determine what state-level actions could support additional scientific review.
You can contact your Louisiana House representatives here to urge them to vote yes on HR 174 and pass this first-of-its-kind resolution.
Updated: They Retracted the 2025 Paper That Proved Fenbendazole Cures Cancer
Here’s Why That Tells You Everything.
The “Reason” — and Why It Is Fabricated
The retraction was ordered by the journal’s Editor, Dr. Maurie Markman, on the grounds that Dr. Makis had an undeclared financial interest — specifically, that at the time of submission he offered services related to the topic of the study, i.e., he treats cancer patients with fenbendazole. The retraction statement noted that “the author’s response when contacted were found to be unsatisfactory” and concluded that “these concerns would have affected the interpretation of the work” (Case Reports in Oncology, 2026).
Read that again and let it sink in.
Fenbendazole is an off-patent, over-the-counter veterinary antiparasitic. It costs pennies per dose. No pharmaceutical company owns exclusive rights to it. No one profits handsomely from its use. As reviewed by Nguyen et al. (2024), fenbendazole’s patent expired in the early 1990s, making it available as a generic drug accessible through animal supply stores and online platforms. The “financial interest” claimed against Dr. Makis — a physician helping patients with a drug that generates essentially no revenue — is not just weak. It is nonsensical.
Now let’s talk about who Dr. Markman actually is and who actually has a financial conflict of interest here.
The Real Conflict of Interest
Dr. Maurie Markman is the President of Medicine and Science at City of Hope Cancer Center. City of Hope is a multi-billion-dollar cancer treatment enterprise that generates its revenue from — you guessed it — cancer treatment. Expensive cancer treatment. Patented cancer treatment. Chemotherapy, immunotherapy, targeted biologics: treatments that cost hundreds of thousands of dollars per patient per year, that are frequently toxic, that often extend life by only weeks to months, and that leave behind a devastating legacy of cancer stem cells that drive relapse and metastasis.
“Thou shalt not bow down thyself to them, nor serve them: for I the LORD thy God am a jealous God, visiting the iniquity of the fathers upon the children unto the third and fourth generation of them that hate me; - Exodus 20:5
49 People With Pancreatic Cancer Who Beat the Death Sentence
Fenbendazole, mebendazole, and ivermectin are producing responses across four continents that oncology’s best chemotherapy cannot match
The Mechanism: Why Antiparasitics Hit PDAC Hard
The foundational argument of my book — Cancer Is a Parasite — is that cancer shares deep biological architecture with parasitic organisms. Nowhere is this convergence more therapeutically relevant than in PDAC. The vulnerabilities that parasites share with pancreatic cancer cells are precisely the vulnerabilities that benzimidazoles and ivermectin have been exploiting for decades in veterinary and human medicine.
Fenbendazole (FBZ) and Mebendazole (MBZ) — Eight Anticancer Mechanisms:
Microtubule Disruption. FBZ binds β-tubulin with high affinity, depolymerizing the mitotic spindle. Cancer cells in rapid division cannot complete mitosis. Cell death follows.
Warburg Effect Blockade. GLUT1 and GLUT4 glucose transporter suppression starves PDAC’s glycolytic dependency. KRAS-driven tumors are extraordinarily glycolytic — cut the glucose, cut the fuel.
p53 Reactivation. FBZ stabilizes and upregulates p53 — the tumor suppressor that PDAC has silenced or mutated. Restored p53 function triggers apoptosis in tumor cells.
Cancer Stem Cell Elimination. Both FBZ and IVM target cancer stem cells — the self-renewing subpopulation responsible for recurrence and chemoresistance that conventional chemotherapy misses entirely.
Multidrug Resistance Reversal. IVM inhibits NF-κB pathway activation and efflux pump overexpression — the primary mechanisms driving PDAC’s notorious resistance to consecutive chemotherapy regimens.
CYP24A1 Inhibition. FBZ blocks CYP24A1 — the enzyme tumors upregulate to destroy local vitamin D (Supple, 2026). Restored vitamin D activity re-enables immune surveillance that PDAC has suppressed.
VEGF Pathway Suppression. FBZ reduces vascular endothelial growth factor signaling — cutting off tumor angiogenesis and, in several cases, contributing to resolution of malignant ascites.
Chemosensitization. IVM reverses tumor resistance to concurrent chemotherapy. Cases consistently show: modest chemo response alone, then dramatic collapse once IVM is added. The mechanism is real and documented.
This is not one mechanism. It is eight — against a cancer that defeats single-pathway therapies by evolving around them. As explained in Cancer is a Parasite, the multimodal logic of antiparasitic treatment is precisely why the case series below shows responses that oncologists call miraculous. It is not a miracle. It is mechanism operating on multiple axes simultaneously.
“Thou shalt not bow down thyself to them, nor serve them: for I the LORD thy God am a jealous God, visiting the iniquity of the fathers upon the children unto the third and fourth generation of them that hate me; - Exodus 20:5
Fenbendazole Is The Superior Anticancer Agent Versus Mebendazole
For many years now this Substack has specified in passing that Fenbendazole was superior to Mebendazole in terms of bioavailability and efficacy for most applications, but in yesterday’s article…
Note: Fenbendazole is identical to Mebendazole, with the only chemical difference being a single atom substitution in their molecular structure: Fenbendazole contains a sulfur atom where Mebendazole contains an oxygen atom. The only reason for this difference is because BigPharma was unable to patent
“Thou shalt not bow down thyself to them, nor serve them: for I the LORD thy God am a jealous God, visiting the iniquity of the fathers upon the children unto the third and fourth generation of them that hate me; - Exodus 20:5